• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.31% Nasdaq Up 0.77%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    94.06 Up 2.76(3.03%) 1:37PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:91.29
    Open:92.80
    Bid:93.86 x 200
    Ask:93.87 x 300
    1y Target Est:122.00
    Beta:1.11
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:92.32 - 94.15
    52wk Range:63.50 - 116.83
    Volume:11,180,319
    Avg Vol (3m):16,826,000
    Market Cap:141.90B
    P/E (ttm):16.76
    EPS (ttm):5.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 3.03%141.90B
    GSKUp 0.91%103.95B
    PFEUp 0.99%199.93B
    RHHBYDown 0.15%232.59B

    Key Statistics

    Forward P/E (1 yr):9.47
    P/S (ttm):6.65
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :7.95
    Quarterly EPS Est (Dec-14) :2.26
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.48

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback